The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life
NCT ID: NCT05195515
Last Updated: 2023-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
2000 participants
OBSERVATIONAL
2022-01-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504
Quality of Life in Patients With Bladder Cancer
NCT00745355
Health-Related Quality of Life in Patients With Bladder Cancer
NCT00744744
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
NCT06350734
Patient-reported Outcomes in Bladder Cancer
NCT03584659
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to understand written and oral Danish
Exclusion Criteria
* Diagnosed other causes explaining the hematuria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
National Research Center for Survivorship and Late Adverse Effects Following Pelvic Organ Cancer, Denmark
UNKNOWN
Aarhus University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jørgen Bjerggaard Jensen
Professor, DMSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jørgen Bjerggaard Jensen, Professor
Role: PRINCIPAL_INVESTIGATOR
Department of Urology, Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Urology, Aarhus University Hospital
Aarhus N, , Denmark
Department of Urology, Regional Hospital Gødstrup
Gødstrup, , Denmark
Department of Urology, Regional Hospital Horsens
Horsens, , Denmark
Department of Urology, Regional Hospital Randers
Randers, , Denmark
Department of Urology, Regional Hospital Viborg
Viborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CONQUER
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.